Quitting While Pregnant

Why this group is different

Pregnancy changes the stakes and the options: the harms of continued smoking affect the developing baby (low birth weight, preterm birth, complications), while medication choices require extra caution because of fetal exposure considerations. The sooner quitting happens, the greater the benefit.

Recommended approach

• Start with behavioral support — face-to-face or telephone counseling is the evidence-based first line
• Quit as early in pregnancy as possible; quitting at any stage still helps
• For pregnant smokers who cannot quit with support alone, some guidelines allow NRT under medical supervision
• Varenicline and bupropion are generally not recommended in pregnancy
• Coordinate all medication decisions with prenatal care providers

What the evidence says

USPSTF and NICE guidance prioritize behavioral support for pregnant smokers. Cochrane reviews find psychosocial interventions effective in pregnancy. Evidence on NRT in pregnancy is less extensive than in non-pregnant adults; where recommended, it is used under supervision and weighed against the known harms of continued smoking.

Evidence strength: Moderate

Medication notes

NRT is considered in some national guidelines when behavioral support alone fails, under medical supervision. Varenicline and bupropion are generally avoided in pregnancy. E-cigarettes are not a recommended cessation aid in pregnancy. Any medication during pregnancy should be decided with a healthcare professional.

Community experience

Community reports describe pregnancy as a uniquely powerful motivator, with many successful quits motivated by the baby's health. Some report quitting cold turkey successfully; others describe strong cravings alongside pregnancy-related stress.